Tracking system for studies should be in place.
作者信息
Delaney J A C
出版信息
BMJ. 2004 Jul 17;329(7458):173. doi: 10.1136/bmj.329.7458.173-b.
Abstract
摘要
相似文献
1
Tracking system for studies should be in place.
BMJ. 2004 Jul 17;329(7458):173. doi: 10.1136/bmj.329.7458.173-b.
2
Putting GlaxoSmithKline to the test over paroxetine.
BMJ. 2013 Nov 12;347:f6754. doi: 10.1136/bmj.f6754.
3
Even more suicide attempts in clinical trials with paroxetine randomised against placebo.
BMC Psychiatry. 2006 Nov 28;6:55. doi: 10.1186/1471-244X-6-55.
4
Re: Paroxetine in the treatment of severe non-dermatological pruritus.
J Pain Symptom Manage. 2005 Feb;29(2):115; author reply 115-6. doi: 10.1016/j.jpainsymman.2004.12.005.
5
GlaxoSmithKline faces US lawsuit over concealment of trial results.
BMJ. 2004 Jun 12;328(7453):1395. doi: 10.1136/bmj.328.7453.1395.
6
Spitzer sues drug giant for deceiving doctors.
Nature. 2004 Jun 10;429(6992):589. doi: 10.1038/429589a.
7
No correction, no retraction, no apology, no comment: paroxetine trial reanalysis raises questions about institutional responsibility.
BMJ. 2015 Sep 16;351:h4629. doi: 10.1136/bmj.h4629.
8
Paxil study under fire.
Nature. 2011 Jul 12;475(7355):153. doi: 10.1038/475153a.
9
Augmentation of paroxetine with clocapramine in panic disorder.
Psychiatry Clin Neurosci. 2007 Aug;61(4):449. doi: 10.1111/j.1440-1819.2007.01690.x.
10
Bias in the design, interpretation, and publication of industry-sponsored clinical research.
Minn Med. 2008 Jun;91(6):46-7.
本文引用的文献
1
GlaxoSmithKline faces US lawsuit over concealment of trial results.
BMJ. 2004 Jun 12;328(7453):1395. doi: 10.1136/bmj.328.7453.1395.
2
A surplus of positive trials: weighing biases and reconsidering equipoise.
Arthritis Res Ther. 2004;6(3):117-9. doi: 10.1186/ar1189. Epub 2004 Apr 27.
3
4
Review articles and publication bias.
Arzneimittelforschung. 1992 May;42(5):587-91.
Zotero 插件